Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-033454
Filing Date
2024-11-06
Accepted
2024-11-06 08:04:11
Documents
88
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20240930c_10q.htm   iXBRL 10-Q 1823763
2 EXHIBIT 10.1 ex_718343.htm EX-10.1 336338
3 EXHIBIT 31.1 ex_718344.htm EX-31.1 17004
4 EXHIBIT 31.2 ex_718345.htm EX-31.2 16999
5 EXHIBIT 32.1 ex_718346.htm EX-32.1 6499
6 EXHIBIT 32.2 ex_718347.htm EX-32.2 6489
  Complete submission text file 0001437749-24-033454.txt   7698598

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20240930.xsd EX-101.SCH 70168
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20240930_cal.xml EX-101.CAL 46859
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20240930_def.xml EX-101.DEF 400022
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20240930_lab.xml EX-101.LAB 347781
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20240930_pre.xml EX-101.PRE 437957
91 EXTRACTED XBRL INSTANCE DOCUMENT urgn20240930c_10q_htm.xml XML 1029289
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 241429304
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)